Evaluating the Oral-Health-Related Quality of Life of Oral Submucous Fibrosis Patients before and after Treatment Using the OHIP-14 Tool
- PMID: 35162842
- PMCID: PMC8835519
- DOI: 10.3390/ijerph19031821
Evaluating the Oral-Health-Related Quality of Life of Oral Submucous Fibrosis Patients before and after Treatment Using the OHIP-14 Tool
Abstract
The objective of the present study was to assess the oral-health-related quality of life (OHRQoL) of oral submucous fibrosis (OSMF) patients before and after standard treatment. A convenient sampling technique was used to recruit the clinically diagnosed patients of OSMF (n = 130). Based on the medical treatment, the patients were randomly divided into two study groups (group A and B). The group A patients received submucosal intralesional injections of dexamethasone (2 mL; 4 gm/mL), while group B patients received hyaluronidase (1500 IU). Both the group A and B patients received respective medical therapy biweekly for a period of five weeks. At the follow up visit (6 months), the impact of treatment on OHRQoL was assessed using the Oral Health Impact Profile-14 (OHIP-14). Data were analyzed by a chi-square test for quantitative variables and an independent t-test for qualitative variables. The comparison of all clinical parameters before and after treatment was performed by a paired t-test. The results after treatment showed that there was a significant improvement in all domains of OHIP-14 (p = 0.001) except psychological disability (p = 0.243). In addition, the OHRQoL of patients was significantly improved following the treatment.
Keywords: oral cancer; oral health; oral potentially malignant disorders; oral submucous fibrosis; quality of life.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Validation of Nepalese Oral Health Impact Profile14 and Assessment of Its Impact in Patients with Oral Submucous Fibrosis in Nepal.J Nepal Health Res Counc. 2015 Jan-Apr;13(29):43-9. J Nepal Health Res Counc. 2015. PMID: 26411712
-
Oral health-related quality of life among male subjects with oral submucous fibrosis in a tertiary care hospital.Indian J Public Health. 2018 Oct-Dec;62(4):271-276. doi: 10.4103/ijph.IJPH_179_17. Indian J Public Health. 2018. PMID: 30539888
-
Comparison of generic and condition-specific oral health-related quality of life instruments in patients with oral submucous fibrosis.Qual Life Res. 2019 Aug;28(8):2281-2288. doi: 10.1007/s11136-019-02176-y. Epub 2019 Apr 1. Qual Life Res. 2019. PMID: 30937730
-
Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis: A meta-analysis.Oral Dis. 2018 Jul;24(5):706-716. doi: 10.1111/odi.12715. Epub 2017 Aug 22. Oral Dis. 2018. PMID: 28737007 Review.
-
The impact of hematological malignancies and their treatment on oral health-related quality of life as assessed by the OHIP-14: a systematic review.Odontology. 2020 Jul;108(3):511-520. doi: 10.1007/s10266-019-00479-7. Epub 2020 Jan 18. Odontology. 2020. PMID: 31955297
Cited by
-
Clinical Assessment of Efficacy of Omega 3 in Oral Submucous Fibrosis Patients - A Randomized Controlled Trial.Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1185-1192. doi: 10.31557/APJCP.2022.23.4.1185. Asian Pac J Cancer Prev. 2022. PMID: 35485674 Free PMC article. Clinical Trial.
-
Validation of the Malay Oral Impacts on Daily Performances and Evaluation of Oral Health-Related Quality of Life in a Multi-Ethnic Urban Malaysian Population: A Cross-Sectional Study.Int J Environ Res Public Health. 2022 Dec 16;19(24):16944. doi: 10.3390/ijerph192416944. Int J Environ Res Public Health. 2022. PMID: 36554823 Free PMC article.
-
Sociodemographic and Clinical Profile of Oral Submucous Fibrosis.Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3373-3378. doi: 10.1007/s12070-023-04004-9. Epub 2023 Jun 23. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37974876 Free PMC article.
-
Comparison of the effectiveness of botulinum toxin, dry needling, pharmacological treatment, and manual therapy for bruxism-induced myalgia: a prospective randomized study.J Oral Facial Pain Headache. 2024 Dec;38(4):101-110. doi: 10.22514/jofph.2024.043. Epub 2024 Dec 12. J Oral Facial Pain Headache. 2024. PMID: 39800961 Free PMC article. Clinical Trial.
-
Interventions for managing oral submucous fibrosis.Cochrane Database Syst Rev. 2024 Feb 28;2(2):CD007156. doi: 10.1002/14651858.CD007156.pub3. Cochrane Database Syst Rev. 2024. PMID: 38415846 Free PMC article.
References
-
- Patil P.G., Hazarey V., Chaudhari R., Nimbalkar-Patil S. A randomized control trial measuring the effectiveness of a mouth-exercising device for mucosal burning in oral submucous fibrosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016;122:713–718. doi: 10.1016/j.oooo.2016.07.026. - DOI - PubMed
-
- Tanwir F., Akhlaq H. Oral submucous fibrosis: A chronic deliberating disease of oral cavity. Iran. J. Pathol. 2011;6:165–172.
-
- Patil P., Hazarey V., Chaudhari R., Nimbalkar-Patil S. Clinical Efficacy of a Mouth-Exercising Device Adjunct to Local Ointment, Intra-Lesional Injections and Surgical Treatment for Oral Submucous Fibrosis: A Randomized Controlled Trial. Asian Pac. J. Cancer Prev. 2016;17:1255–1259. doi: 10.7314/APJCP.2016.17.3.1255. - DOI - PubMed
-
- Regezi J., Sciubba J., Jordan R. In: Oral Pathology: Clinical Pathologic Correlations. Dolan J., editor. Elsevier; Amsterdam, The Netherlands: 2016.
-
- Jontell M., Holmstrup P., Ship J. Red and white lesions of the oral mucosa. Burket’s Oral Med. 2008;1:77–78.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources